Isto Nordback
Overview
Explore the profile of Isto Nordback including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nikkola A, Makela K, Herzig K, Mutt S, Prasannan A, Seppanen H, et al.
Int J Mol Sci
. 2022 Dec;
23(24).
PMID: 36555366
Only 3-5% of heavy alcohol users develop acute alcohol pancreatitis (AAP). This suggests that additional triggers are required to initiate the inflammatory process. Genetic susceptibility contributes to the development of...
2.
Aronen A, Aittoniemi J, Huttunen R, Nikkola A, Rinta-Kiikka I, Nikkola J, et al.
Scand J Gastroenterol
. 2020 Nov;
56(1):81-85.
PMID: 33245246
Objectives: SuPAR (soluble urokinase-type plasminogen activator receptor) is a biomarker reflecting the inflammatory state of the human body. Earlier studies suggest that urinary suPAR/creatinine ratio levels are elevated in chronic...
3.
Aronen A, Aittoniemi J, Huttunen R, Nikkola A, Nikkola J, Limnell O, et al.
Eur J Intern Med
. 2019 May;
64:72-75.
PMID: 31060962
Background: Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker associated with inflammatory and certain malignancies. Earlier we have shown that plasma suPAR (P-suPAR) predicts severity of acute alcohol-induced pancreatitis...
4.
Quality of life in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy
Laitinen I, Sand J, Peromaa P, Nordback I, Laukkarinen J
Pancreatology
. 2017 Mar;
17(3):445-450.
PMID: 28274687
Introduction: Survival for pancreatic ductal adenocarcinoma (PDAC) is relatively short even after complete resection. Pancreaticoduodenectomy (PD) carries a high risk for postoperative morbidity, and the effect on quality of life...
5.
Nikkola J, Laukkarinen J, Lahtela J, Seppanen H, Jarvinen S, Nordback I, et al.
J Clin Gastroenterol
. 2017 Jan;
51(2):183-190.
PMID: 28060789
Background: Data on the prevalence of pancreatic dysfunction after an episode of acute pancreatitis are conflicting. Our aim was to evaluate the natural course of endocrine and exocrine pancreatic function...
6.
Karvonen S, Nordback I, Elo J, Havulinna J, Laine H
HERD
. 2016 Dec;
10(3):142-151.
PMID: 27899440
Objective: The objective of the present study was to describe how a specific patient flow analysis with from-to charts can be used in hospital design and layout planning. Background: As...
7.
Tyrvainen T, Nordback I, Toikka J, Piiroinen A, Herzig K, Makela K, et al.
Scand J Gastroenterol
. 2016 Nov;
52(3):334-337.
PMID: 27881023
Background And Aims: The incidence of gallstones and gallbladder sludge is higher in patients after total gastrectomy than in general population. Formation of gallstones after gastrectomy is multifactorial. Here, we...
8.
Nikkola A, Aittoniemi J, Huttunen R, Rajala L, Nordback I, Sand J, et al.
Pancreas
. 2016 Nov;
46(1):77-82.
PMID: 27841794
Objectives: Systemic levels of soluble urokinase-type plasminogen activator receptor (suPAR) are increased in various inflammatory and infectious diseases. We investigated the activation and prognostic value of plasma suPAR (P-suPAR) in...
9.
Laaninen M, Sand J, Nordback I, Vasama K, Laukkarinen J
Ann Surg
. 2016 Jul;
264(5):696-702.
PMID: 27429037
Objectives: The aim of this study was to study whether post-pancreaticoduodenectomy complications (PPDC) in high-risk patients can be reduced with hydrocortisone. Background: Soft pancreas is a well-known risk factor for...
10.
Siiki A, Jesenofsky R, Lohr M, Nordback I, Kellomaki M, Grohn H, et al.
Scand J Gastroenterol
. 2016 Mar;
51(7):880-5.
PMID: 27003149
Background: Benign biliary strictures (BBS) are primarily treated endoscopically with covered self-expandable metal stents (CSEMS). Biodegradable biliary stents (BDBS) may be the future of endoscopic therapy of BBS. The aim...